CVS Caremark Insights report reveals 3.8% boost in 2013 drug trend
WOONSOCKET, R.I. — Prescription drug trend grew 3.8% in 2013, driven by significant price inflation for traditional brand drugs, specialty drugs and generics, as well as an increase in utilization as members filled more prescriptions in the slowly improving economy, according to the findings of CVS Caremark’s annual "Insights" report released on Thursday. This compares with 2012, which experienced nearly flat growth at 0.1%.
The CVS Caremark "Insights" report, which reviews drug trend and highlights key issues in pharmacy care, analyzes these trends and outlines a number of strategies healthcare payers can adopt to help manage prescription drug spending. Prescription drug trend is the measure of growth in prescription spending per member per month. Trend calculations take into account the effects of drug price, drug utilization and the mix of branded versus generic drugs.
While spending for traditional medications was up just 0.8% in 2013, this compares to a trend that actually declined 3.8% in 2012. The driver of overall trend in 2013 was specialty medications, which grew by 15.6%. Specialty drugs treat more complex diseases, such as multiple sclerosis, rheumatoid arthritis, hepatitis C and cancer. Overall, specialty drugs now represent nearly 22.5% of total drug spend among CVS Caremark clients, a relative increase of more than 10% in a single year.
"As our clients are faced with the pressure of rising prescription drug trend, CVS Caremark is well-positioned to help them manage this impact through a variety of unique programs that encourage the use of lower-cost generics; improve the management of specialty medications across the medical and pharmacy benefit and site of care; and control price inflation through aggressive formulary management and use of narrow networks," said Jon Roberts, president of CVS Caremark’s PBM business.
The company also reported a record generic dispensing rate of 81.4% in 2013. While the generic pipeline is dwindling over the next few years, CVS Caremark analysis indicates that not every client has truly maximized their existing generic opportunities, leaving continued room for improvement and savings.
"This year’s Insights report outlines seven sure things that our clients should keep in mind," Roberts said. "These include: prescription trend is up, generics have peaked, specialty drives trend, price is king, money matters to members, adherence is the answer and past performance is no guarantee of future results. This is not just a catchy list of factors that impact drug trend, these are key concepts for our clients to consider when determining how to maximize their prescription drug benefit in the complex and changing healthcare landscape."
The "Insights" report highlights five specific strategies to help clients save money and improve the health of their patients in the years ahead:
- Double down on generics: Analysis of generic utilization, managed formulary options and new specialty generics can help slow overall trend;
- Look across benefits at specialty: Recent research commissioned by CVS Caremark found transitioning targeted specialty medication spend from the medical to the pharmacy benefit can save an average of 19%;
- Tackle price: Narrow pharmacy networks can help lower costs for payers, particularly when combined with convenient options like mail service delivery;
- Be strategic about cost share: Member cost-share can affect where prescriptions get filled, which drugs members ask for and even if members fill their prescriptions. Clients should align their cost-share strategies with their overall plan goals and provide support to help their members understand their prescription therapy; and
- Keep the big picture in mind: Helping members stay healthy can help reduce prescription trend and overall cost growth. In addition, managing the whole patient can help reduce hospitalizations, readmissions and emergency department visits, helping manage overall costs.
The CVS Caremark "Insights" report addresses prescription drug use for members with prescription benefits provided by CVS Caremark during the 2013 calendar year. The 2013 cohort studied includes 22.9 million members across the commercial segments (i.e., health plan and employer), as well as Medicare Part D and Medicaid plans.
Click here to access the full Insights report.
Wow, in increase in drug consumption. Yet chains continue to cut and hack their support staff (e.g. pharmacy technicians) to nothing while the execs, who have clearly lost any real grasp of what is involved in running a pharmacy today continue to be confused why customer satisfaction continues to plummet even as they roll out program after program focusing on customer service because they fail to understand customer service is the result of the expereince of providing your business' service; it is not some nebulous entitiy of its own, which it has bene turned into. In short on top of decreased staffing we now spend so much time doumenting customer service that we never actually have time to actually provide it.
Fred’s Super Dollar reports March sales of $191.2 million, up 1%
MEMPHIS, Tenn. — Fred’s Super Dollar on Wednesday reported sales of $191.2 million, up 1%, for the five-week fiscal month of March ended April 5, 2014.
Comparable store sales for the month decreased 1.2% compared with a decrease of 3% in the prior-year period.
"As we discussed on our earnings conference call, March general merchandise sales would be challenged by the calendar shift of the Easter holiday from March last year to April this year, which was compounded by the continuing unseasonably cool weather we experienced across our market region," stated Bruce Efird, Fred’s CEO. "Looking beyond the weather and Easter-shift challenges in general merchandise, we continue to be pleased with the positive performance of our reconfiguration departments, most notably auto, hardware and pharmacy. Looking ahead, we expect stronger sales in April, as our stores are well-prepared, and we look forward to the arrival of the spring season and the Easter holiday."
Efird added that Fred’s plans to retrofit approximately 70 stores during April, resulting in approximately 60% of the chain being reconfigured through first quarter 2014.
During March, Fred’s opened one new store with a pharmacy and closed two stores without pharmacies.
No comments found
Ambi expands product portfolio with two new launches
NEW YORK — Ambi, a beauty brand for women of color, is expanding its portfolio with the new Ambi Advanced 5% Micro-Benzoyl Peroxide Acne Spot Treatment and Ambi Even & Clear Makeup Removing Cleansing Cloths.
AMBI Advanced 5% Micro-Benzoyl Peroxide Acne Spot Treatment fights acne blemishes. The micro-encapsulated benzoyl peroxide in the formula helps deliver acne-fighting medicine deep into pores for effective results with less irritation. This product has special relevance for skin of color, which is three times as likely to develop dark spots from acne blemishes than other skin tones.
Recent trends also have revealed that the use of foundation and color cosmetics has increased over the past three years among women of color. As a result, there is a desire to have a quick and easy way to gently cleanse skin and effectively remove oil, dirt and signs of makeup, without a dry after-feel, the company stated. Ambi Even & Clear Makeup Removing Cleansing Cloths provide a soap-free formula with moisturizing ingredients that are contained within soft towelettes.
Ambi Advanced 5% Micro-Benzoyl Peroxide Acne Spot Treatment and Ambi Even & Clear Makeup Removing Cleansing Cloths will be available at national mass, drug and beauty supply stores in May for $5.99 each.
No comments found